Clinical Trial Update: European Stop Tyrosine Kinase Inhibitor Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for a study on tyrosine kinase inhibitors in chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: European LeukemiaNet | Conditions: Chronic Myeloid Leukemia | Phase 3 | Status: COMPLETED